Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Squalene synthase inhibitors reported by RPR

Nov. 8, 1996

Yamanouchi discloses hypocholesterolemic agents

Nov. 8, 1996

NPS and SKB extend osteoporosis research collaboration

Nov. 8, 1996

Interpore and Quantic to develop cartilage repair product

Nov. 8, 1996

TheraTech's testosterone patch now being tested in women with sexual dysfunction

Nov. 1, 1996

New, more convenient testosterone transdermal patch submitted for approval

Nov. 1, 1996

FDA begins review of Oxandrin

Nov. 1, 1996

Growth hormone secretion stimulants claimed by Merck & Co.

Nov. 1, 1996

Pulmonary-delivered insulin advances through clinical trials

Nov. 1, 1996

Lilly reports long-acting, soluble insulin analogues

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...